Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of December 20, 2024 • 12:00 AM ET

Date/Time Source News Release
11/26/2024 08:30 AM EST GlobeNewswire Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders
11/05/2024 08:30 AM EST GlobeNewswire Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
10/21/2024 08:30 AM EDT GlobeNewswire Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss
10/16/2024 08:30 AM EDT GlobeNewswire Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress
09/11/2024 08:30 AM EDT GlobeNewswire Veru to Present at the 2024 Cantor Global Healthcare Conference
08/08/2024 06:30 AM EDT GlobeNewswire Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results
08/01/2024 08:30 AM EDT GlobeNewswire Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024
07/29/2024 08:30 AM EDT GlobeNewswire Veru to Participate in the BTIG Virtual Biotechnology Conference
07/02/2024 08:30 AM EDT GlobeNewswire Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism
06/24/2024 08:30 AM EDT GlobeNewswire Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions
Page

Additional News

As of December 20, 2024 • 12:00 AM ET

Date/Time Source News Release
12/16/2024 07:00 PM EST Zacks Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates
12/13/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Friday, December 13th, 2024
12/13/2024 04:31 AM EST US Earnings Reports Expected earnings - Veru Inc.
12/05/2024 05:25 PM EST Zacks The Cooper Companies (COO) Q4 Earnings Beat Estimates
11/19/2024 07:55 AM EST Zacks Medtronic (MDT) Surpasses Q2 Earnings and Revenue Estimates
11/14/2024 05:25 PM EST Zacks Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates
10/12/2024 01:58 PM EDT SeekingAlpha Weight loss drugs have one big issue; These companies want to fix it
08/10/2024 08:39 AM EDT SeekingAlpha Veru Inc. (VERU) Q3 2024 Earnings Call Transcript
08/08/2024 07:45 AM EDT Zacks Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates
08/08/2024 06:47 AM EDT SeekingAlpha Veru GAAP EPS of -$0.07, revenue of $4M
Page